Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study.

[1]  R. Scolyer,et al.  Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  M. Alter,et al.  Which parameters to choose for prediction of non-sentinel lymph node positivity in melanoma? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  W. Jurecka,et al.  Value of micromorphometric criteria of sentinel lymph node metastases in predicting further nonsentinel lymph node metastases in patients with melanoma , 2011, Melanoma research.

[4]  J. McCaffrey,et al.  A phase II study of lapatinib and capecitabine in first-line treatment of metastatic pancreatic cancer (ICORG 08- 39). , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  R. Scolyer,et al.  Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  G. Botti,et al.  Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome , 2010, Cancer biology & therapy.

[7]  F. Wright,et al.  Validation of a scoring system to predict non‐sentinel lymph node metastasis in melanoma , 2009, Journal of surgical oncology.

[8]  I. V. D. van der Ploeg,et al.  Comparison of Three Micromorphometric Pathology Classifications of Melanoma Metastases in the Sentinel Node , 2009, Annals of surgery.

[9]  Jeffrey E. Lee,et al.  Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R. Scolyer,et al.  Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients , 2007, Histopathology.

[11]  M. Binder,et al.  Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[12]  K. Delman,et al.  Prediction of Nonsentinel Lymph Node Involvement in Patients with a Positive Sentinel Lymph Node in Malignant Melanoma , 2007, The American surgeon.

[13]  W. Jurecka,et al.  S-classification of sentinel lymph node biopsy predicts the results of complete regional lymph node dissection , 2005, Melanoma research.

[14]  Jennifer L. Schwartz,et al.  Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. , 2005, Journal of the American College of Surgeons.

[15]  R. Scolyer,et al.  Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. , 2004, American journal of clinical pathology.

[16]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.